Chun Bao Yang
Direktor/Vorstandsmitglied bei SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD.
Profil
Chun Bao Yang currently works at Shanghai Qingpu Fire Fighting Equipment Co., Ltd., as Independent Non-Executive Director from 2000 and Shanghai Huashen Certified Public Accountants Ltd., as Accountant from 2011.
Mr. Yang also formerly worked at Mingyuan Medicare Development Co. Ltd., as Independent Non-Executive Director from 2014 to 2016.
Mr. Yang received his graduate degree in 1999 from Madonna University.
Aktive Positionen von Chun Bao Yang
Unternehmen | Position | Beginn |
---|---|---|
SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD. | Direktor/Vorstandsmitglied | 01.10.2000 |
Shanghai Huashen Certified Public Accountants Ltd. | Corporate Officer/Principal | 01.11.1973 |
Ehemalige bekannte Positionen von Chun Bao Yang
Unternehmen | Position | Ende |
---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Direktor/Vorstandsmitglied | 20.05.2016 |
Ausbildung von Chun Bao Yang
Madonna University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD. | Electronic Technology |
Private Unternehmen | 2 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
Shanghai Huashen Certified Public Accountants Ltd. |